About Organ Transplant Immunosuppressant An organ transplantation is a surgical procedure that involves replacing diseased organs such as a heart, liver, kidney, or lung with healthy organs. The donor organ can come from a deceased donor (who has recently passed away) such as in heart transplants, or kidney, liver, and rarely lung transplants from living donors. As per the Centers for Disease Control and Prevention (CDC) report, the most commonly transplanted organs in the US are the kidney, liver, heart, lungs, pancreas, and intestine. On any given day, there are about 75,000 people on active waiting list for organ transplantation. However, the organ donors are very few, leading to the high unmet need for organ availability. There are only 8,000 deceased organ donors annually, with each providing on average 3.5 organs. Living donors provide on average only around 6,000 organs per year. Technavio’s analysts forecast the global organ transplant immunosuppressant market to grow at a CAGR of 3.81% during the period 2017-2021. Covered in this report The report covers the present scenario and... Research Beam Model: Research Beam Product ID: 1697063 3500 USD New
Global organ transplant immunosuppressant market 2017-2021
 
 

Global organ transplant immunosuppressant market 2017-2021

  • Category : Healthcare
  • Published On : July   2017
  • Pages : 128
  • Publisher : Technavio
 
 
 
About Organ Transplant Immunosuppressant
An organ transplantation is a surgical procedure that involves replacing diseased organs such as a heart, liver, kidney, or lung with healthy organs. The donor organ can come from a deceased donor (who has recently passed away) such as in heart transplants, or kidney, liver, and rarely lung transplants from living donors. As per the Centers for Disease Control and Prevention (CDC) report, the most commonly transplanted organs in the US are the kidney, liver, heart, lungs, pancreas, and intestine. On any given day, there are about 75,000 people on active waiting list for organ transplantation. However, the organ donors are very few, leading to the high unmet need for organ availability. There are only 8,000 deceased organ donors annually, with each providing on average 3.5 organs. Living donors provide on average only around 6,000 organs per year.


Technavio’s analysts forecast the global organ transplant immunosuppressant market to grow at a CAGR of 3.81% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global organ transplant immunosuppressant market for 2017-2021. To calculate the market size, the report considers the sales of both branded and generic drugs.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio's report, Global Organ Transplant Immunosuppressant Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Novartis,
• Astellas Pharma,
• Pfizer,
• Sanofi,
Other prominent vendors
• AbbVie
• Bristol-Myers Squibb
• F. Hoffmann-La Roche
Market driver
• Increased incidence of organ failure
• For a full, detailed list, view our report

Market challenge
• Insufficient organ supply
• For a full, detailed list, view our report

Market trend
• Growing trend of medical tourism
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.




PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• Market outline
PART 05: Introduction to organ transplantation
• What is an organ transplantation?
• How common is organ transplantation?
• Increasing trend of organ transplantation
• Need for immunosuppression during organ transplant
• What is an immunosuppressant?
• Role of an immunosuppressant during organ transplant
PART 06: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 07: Key clinical trials
PART 08: Market segmentation by drug class
• Selective inhibitor of cytokine production and function
• Immunosuppressive antimetabolites
• Immunosuppressive antibodies
• Immunosuppressive adrenocorticosteroids
PART 09: Market segmentation by therapeutic application
• Kidney transplantation
• Liver transplantation
• Heart transplantation
• Lung transplantation
• Pancreas transplantation
• Other transplantation
PART 10: Geographical segmentation
• Organ transplant immunosuppressant market in Americas
• Organ transplant immunosuppressant market in EMEA
• Organ transplant immunosuppressant market in APAC
PART 11: Decision framework
PART 12: Drivers and challenges
• Market drivers
• Market challenges
PART 13: Market trends
• Growing trend of medical tourism
• New government initiatives on transplant research programs
• Growing focus toward the use of biologics
PART 14: Vendor landscape
• Competitive scenario
PART 15: Key vendor analysis
• Astellas Pharma
• Novartis
• Pfizer
• Sanofi
• Other prominent vendors
PART 16: Appendix
• List of abbreviations

PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 
REQUEST SAMPLE    ASK FOR DISCOUNT